NV Bekaert SA (BEKAY)
OTCMKTS · Delayed Price · Currency is USD
3.500
-0.015 (-0.43%)
At close: Feb 3, 2025
CTI BioPharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 173.95 | 238.9 | 254.62 | 268.86 | 404.06 | 134.69 | Upgrade |
Depreciation & Amortization | 166.92 | 166.92 | 166.91 | 188.7 | 180.89 | 197.29 | Upgrade |
Other Amortization | 7.27 | 7.27 | 6.04 | 3.72 | 3.57 | 4.82 | Upgrade |
Loss (Gain) From Sale of Assets | -4.63 | -4.63 | -4.11 | -11.86 | -23.23 | -38.63 | Upgrade |
Asset Writedown & Restructuring Costs | 9.78 | 9.78 | 10.81 | 57.93 | -1.52 | 13.96 | Upgrade |
Stock-Based Compensation | -5.02 | -5.02 | -0.26 | 0.09 | 15.26 | 8.56 | Upgrade |
Provision & Write-off of Bad Debts | 19.93 | 19.93 | -1.67 | -2.04 | -1.41 | -0.4 | Upgrade |
Other Operating Activities | 28.7 | -58.71 | -1.03 | -48.88 | -44.73 | 60.77 | Upgrade |
Change in Accounts Receivable | -26.31 | -26.31 | 70.83 | 41.63 | -27.41 | -1.23 | Upgrade |
Change in Inventory | -14.27 | -14.27 | 152.53 | -12.07 | - | - | Upgrade |
Change in Accounts Payable | 27.93 | 27.93 | -181.18 | -163.93 | - | - | Upgrade |
Change in Other Net Operating Assets | 58.63 | 12.18 | -33.65 | -30.53 | -124.98 | 125.09 | Upgrade |
Operating Cash Flow | 442.88 | 373.97 | 439.83 | 340.29 | 380.49 | 504.92 | Upgrade |
Operating Cash Flow Growth | 12.42% | -14.97% | 29.25% | -10.56% | -24.64% | -3.70% | Upgrade |
Capital Expenditures | -173.26 | -196.07 | -191.26 | -170.2 | -143.75 | -104.48 | Upgrade |
Sale of Property, Plant & Equipment | 1.9 | 9.81 | 14.97 | 3.01 | 35.92 | 52.14 | Upgrade |
Cash Acquisitions | -3.51 | -39.17 | -5.86 | -2.38 | - | -0.98 | Upgrade |
Sale (Purchase) of Intangibles | -26.93 | -25.66 | -18.72 | -14.81 | -8.62 | -3.21 | Upgrade |
Investment in Securities | 20.98 | -0.18 | 100.45 | -8.52 | -0.93 | - | Upgrade |
Other Investing Activities | 43.54 | 50.93 | 59.89 | 67.95 | 25.57 | 25.32 | Upgrade |
Investing Cash Flow | -137.26 | -200.36 | -40.53 | -124.96 | -91.81 | -31.21 | Upgrade |
Short-Term Debt Issued | - | - | - | 67.35 | - | 41.36 | Upgrade |
Long-Term Debt Issued | - | 2.38 | 0.03 | 12.05 | 23.65 | 201.31 | Upgrade |
Total Debt Issued | 133.68 | 2.38 | 0.03 | 79.4 | 23.65 | 242.67 | Upgrade |
Short-Term Debt Repaid | - | -47.55 | -36.92 | - | -43.33 | - | Upgrade |
Long-Term Debt Repaid | - | -107.84 | -217.43 | -87.63 | -439.82 | -247.67 | Upgrade |
Total Debt Repaid | -243.72 | -155.38 | -254.35 | -87.63 | -483.15 | -247.67 | Upgrade |
Net Debt Issued (Repaid) | -110.04 | -153 | -254.32 | -8.23 | -459.5 | -5.01 | Upgrade |
Issuance of Common Stock | - | - | - | 0.75 | 18.5 | 1.08 | Upgrade |
Repurchase of Common Stock | -64.73 | -30.07 | -99.37 | -97.1 | - | - | Upgrade |
Common Dividends Paid | -95.87 | -93.76 | -88.56 | -86.46 | -56.8 | -19.79 | Upgrade |
Other Financing Activities | -25.5 | -30.03 | -39.86 | 16.65 | -69.28 | -59.03 | Upgrade |
Financing Cash Flow | -296.12 | -306.86 | -482.11 | -174.4 | -567.08 | -82.74 | Upgrade |
Foreign Exchange Rate Adjustments | -27.39 | 5.94 | -13.6 | 9.89 | 15.26 | -16.73 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | 0 | -0 | - | 0 | Upgrade |
Net Cash Flow | -17.89 | -127.3 | -96.41 | 50.83 | -263.15 | 374.24 | Upgrade |
Free Cash Flow | 269.62 | 177.9 | 248.57 | 170.1 | 236.74 | 400.44 | Upgrade |
Free Cash Flow Growth | 31.84% | -28.43% | 46.14% | -28.15% | -40.88% | -6.83% | Upgrade |
Free Cash Flow Margin | 7.00% | 4.50% | 5.74% | 3.40% | 4.89% | 10.62% | Upgrade |
Free Cash Flow Per Share | 5.19 | 3.39 | 4.61 | 3.00 | 4.11 | 6.24 | Upgrade |
Cash Interest Paid | 28.61 | 28.61 | 35.36 | 37.43 | 35.17 | 42.86 | Upgrade |
Cash Income Tax Paid | 69.42 | 69.42 | 79.16 | 117.29 | 92.74 | 56.5 | Upgrade |
Levered Free Cash Flow | 223.05 | 98.86 | 408.17 | 59.88 | 140.61 | 370.7 | Upgrade |
Unlevered Free Cash Flow | 245.29 | 122.6 | 433.23 | 81.16 | 168.41 | 407.92 | Upgrade |
Change in Net Working Capital | -109.05 | 39.8 | -227.12 | 175.84 | 193.98 | -132.3 | Upgrade |
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.